Type 2 diabetes and frequency of prevention and control measures

被引:30
|
作者
Jimenez-Corona, Aida [1 ]
Aguilar-Salinas, Carlos A. [2 ]
Rojas-Martinez, Rosalba [1 ]
Hernandez-Avila, Mauricio [1 ]
机构
[1] Inst Nacl Salud Publ, Cuernavaca 62100, Morelos, Mexico
[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
来源
SALUD PUBLICA DE MEXICO | 2013年 / 55卷
关键词
type 2 diabetes mellitus; primary prevention; quality of health care; Mexico; GLYCEMIC CONTROL; LATIN-AMERICA; HEALTH;
D O I
10.21149/spm.v55s2.5109
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective. To determine the frequency of application of prevention and control measures for type 2 diabetes in Mexican population. Materials and methods. ENSANUT 2012 is a nationally and by-state representative survey. Sample design was probabilistic, multistage, stratified and clustered. The information of 46 277 adults >= 20 was used for this analysis. A weighted analysis was performed using Stata 12. Results. Prevalence of diabetes by previous diagnosis was 9.2% (6.4 millions) in ENSANUT 2012, 7.3% (3.7 millions) in 2006 and 4.6% (2.1 millions) in 2000. In 2012, the mean of medical examinations in the previous year related to diabetes control was 7.3. However, the percentage of cases in which preventive actions for chronic complications were performed (such as foot care [14.6%], ophthalmology [8.6%] and determination of HbA1c [9.6%]) was low. Conclusions. Patients with diabetes have frequent access to medical services. However, preventive actions are applied insufficiently both in quality and quantity.
引用
收藏
页码:S137 / S143
页数:7
相关论文
共 50 条
  • [1] Type 2 diabetes mellitus in Yakutia: prevention measures
    Zakharova, L. S.
    Semenov, S. I.
    Platonov, F. A.
    Lebedeva, U. M.
    Krivoshapkin, V. G.
    Fedorova, M. A.
    YAKUT MEDICAL JOURNAL, 2011, (04): : 116 - 116
  • [2] Prevention of Type 2 Diabetes
    Fritsche, A.
    Stefan, N.
    DIABETOLOGIE UND STOFFWECHSEL, 2012, 7 (06) : R51 - R59
  • [3] Prevention of type 2 diabetes
    Samy I. McFarlane
    John J. Shin
    Tanja Rundek
    J. Thomas Bigger
    Current Diabetes Reports, 2003, 3 (3) : 235 - 241
  • [4] Prevention of type 2 diabetes
    Yale, JF
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, : 35 - 39
  • [5] The prevention of type 2 diabetes
    Crandall, Jill P.
    Knowler, William C.
    Kahn, Steven E.
    Marrero, David
    Florez, Jose C.
    Bray, George A.
    Haffner, Steven M.
    Hoskin, Mary
    Nathan, David M.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (07): : 382 - 393
  • [6] Prevention of type 2 diabetes
    Schwarz, P. E. H.
    Koehler, D.
    Hoffmann, R.
    Landgraf, R.
    DIABETOLOGE, 2009, 5 (06): : 471 - 484
  • [7] Prevention of Type 2 Diabetes
    Weber, Mary Beth
    Hassan, Saria
    Quarells, Rakale
    Shah, Megha
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2021, 50 (03) : 387 - 400
  • [8] Prevention of type 2 diabetes
    Pittas, AG
    LABORATORY MEDICINE, 2003, 34 (11) : 790 - 795
  • [9] Prevention of type 2 diabetes
    Goldberg, RB
    MEDICAL CLINICS OF NORTH AMERICA, 1998, 82 (04) : 805 - +
  • [10] Prevention of type 2 diabetes
    Laakso, M
    CURRENT MOLECULAR MEDICINE, 2005, 5 (03) : 365 - 374